Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer
NCT04751747 is an interventional trial sponsored by Rutgers, The State University of New Jersey. As of 21 Nov 2026, it is active and no longer recruiting. It studies Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma and 11 more conditions. The registry lists an enrollment of 34 participants at 2 sites in 1 country. The registry lists a start date of 11 Feb 2021 and a primary completion date of 31 Dec 2026. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04751747 |
| Status | Active not recruiting |
| Study type | Interventional trial |
| Lead sponsor | Rutgers, The State University of New Jersey |
| Enrollment | 34 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 and 7 more conditions |
| Start | 11 Feb 2021 |
| Primary completion | 31 Dec 2026 |
| Study completion | 31 Dec 2027 |
| Last update posted | 11 Jun 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rwjbarnabas Health - Robert Wood Johnson University Hospital
New Brunswick
- Rutgers Cancer Institute of New Jersey
New Brunswick
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04751747
Each answer restates registry values shown on this page.
What is NCT04751747?
NCT04751747 is an interventional trial sponsored by Rutgers, The State University of New Jersey. It studies Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma and 11 more conditions.
Is NCT04751747 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT04751747?
The registry names Salma K Jabbour, MD (principal investigator, Rutgers Cancer Institute of New Jersey) as the overall official.
Where does NCT04751747 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When is NCT04751747 expected to complete?
The registry lists a primary completion date of 31 Dec 2026 and a study completion date of 31 Dec 2027. The sponsor last updated the record on 11 Jun 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.